摘要
[目的]评价母牛分枝杆菌复治肺结核病人的疗效。[方法]选取168例复治肺核病人采用单盲,开放平行试验依随机表分为治疗组、对照组。[结果]痰菌阴转率,病灶吸收率,空洞闭合率,症状好转体重增加率,治疗组与对照组相比差异有统计学意义(P﹤0.05)。[结论]免疫调节剂母牛分枝杆菌,在复治肺结核病人的联合应用是有效可行的。
[ Objective ] To evaluate the curative effect of mycobacterium vaccaein the retreatment of tuberculosis patents. [Methods] Selected 168 casesof tuberculosis patients retreated using single-blind method, then randomly divided into control group and treatment group to carry out open parallel test. [ Results] Sputum conversion rate. the focus absorption rate, empty closure rate, weight gain rate. improvement in symptoms in the treatment group were significantly different comparing with those in the control group （P 〈 0.05）. [Conclusion] Mycobacterium vaccae is feasible and effective in the associated apphcation to retreat tuberculosis patients.
出处
《现代预防医学》
CAS
北大核心
2008年第17期3409-3410,共2页
Modern Preventive Medicine
关键词
母牛分枝杆菌
复治耐药肺结核
联合应用
监床观察
Mycobacterium vaccae
Resistant pulmonary tuberculosis
Associated application
Clinical observation
